Published 1/13/2026
Crowley BM, Boshoff HI, Boving A, Tan VY, Zhu J, Hoyt F, Miller RR, Ehrhart J, Boyce CW, Young K, Nantermet PG, Su J, Yang L, Painter RE, Corcoran EB, Hoar JL, Oh S, Holtzman DL, Levi M, Anderson A, Otieno MA, Zimmerman M, Kaya F, Massoudi LM, Ramey ME, Bauman AA, Lenaerts AJ, Roberston GT, Dartois V, Wells CD, Barry CE, Olsen DB. Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis. Nat Med. 2026 Feb; 32(2):553-560. PMID: 41530381.